Skip to main content

Journal of Hematology & Oncology

Ausgabe 1/2010

Inhalt (51 Artikel)

Open Access Letter to the Editor

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

Pimjai Niparuck, Ladda Sorakhunpipitkul, Vichai Atichartakarn, Suporn Chuncharunee, Artit Ungkanont, Pantep Aungchaisuksiri, Teeraya Puavilai, Saengsuree Jootar

Open Access Case report

Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers

Giovanni Ponti, Gabriele Luppi, Lorena Losi, Alberto Giannetti, Stefania Seidenari

Open Access Case report

Complete response to FOLFOX4 therapy in a patient with advanced urothelial cancer: a case report

Yu Ri Seo, Se Hyung Kim, Hyun Jung Kim, Chan Kyu Kim, Seong Kyu Park, Eun Suk Koh, Dae Sik Hong

Open Access Review

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo, Delong Liu

Open Access Research

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment

Saloomeh Vahdat, Eric K Oermann, Sean P Collins, Xia Yu, Malak Abedalthagafi, Pedro DeBrito, Simeng Suy, Shadi Yousefi, Constanza J Gutierrez, Thomas Chang, Filip Banovac, Eric D Anderson, Giuseppe Esposito, Brian T Collins

Open Access Review

Ovarian cancer immunotherapy: opportunities, progresses and challenges

Bei Liu, John Nash, Carolyn Runowicz, Helen Swede, Richard Stevens, Zihai Li

Open Access Review

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

Christophe Frémin, Sylvain Meloche

Open Access Research

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

John J Kavanagh, Charles F Levenback, Pedro T Ramirez, Judith L Wolf, Carla L Moore, Marsha R Jones, Lisa Meng, Gail L Brown, Robert C Bast Jr

Open Access Research

RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy

Song Dong, Ai-Lin Guo, Zhi-Hong Chen, Zhen Wang, Xu-Chao Zhang, Ying Huang, Zhi Xie, Hong-Hong Yan, Hua Cheng, Yi-Long Wu

Open Access Case report

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature

Marnelli A Bautista, W Tait Stevens, Chien-Shing Chen, Brian R Curtis, Richard H Aster, Chung-Tsen Hsueh

Open Access Review

Applying mass spectrometry based proteomic technology to advance the understanding of multiple myeloma

Johann Micallef, Moyez Dharsee, Jian Chen, Suzanne Ackloo, Ken Evans, Luqui Qiu, Hong Chang

Open Access Research

CD7 in acute myeloid leukemia: correlation with loss of wild-type CEBPA, consequence of epigenetic regulation

Sonja Röhrs, Michaela Scherr, Julia Romani, Margarete Zaborski, Hans G Drexler, Hilmar Quentmeier

Open Access Case report

Oral Ezatiostat HCl (TLK199) and Myelodysplastic syndrome: A case report of sustained hematologic response following an abbreviated exposure

Fahd Quddus, Jessica Clima, Helen Seedham, Ghulam Sajjad, Naomi Galili, Azra Raza

Open Access Editorial

Sweet fruit from a poisonous kiss

Delong Liu

Open Access Letter to the Editor

An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China

Bao-An Chen, Zhi-Hu Huang, Xiao-Ping Zhang, Jian Ou-Yang, Jian-Yong Li, Yong-Ping Zhai, Xue-Mei Sun, Yan-Li Xu, Qin Lu, Jian-Min Wang, Dong Li, Hui Liao, Zhi-Xiang Shen, Yan-Yan Wang, Xiao-Jing Yu, Hui Ye, Li-Ying Zhuang

Open Access Research

CyberKnife® enhanced conventionally fractionated chemoradiation for high grade glioma in close proximity to critical structures

Eric Oermann, Brian T Collins, Kelly T Erickson, Xia Yu, Sue Lei, Simeng Suy, Heather N Hanscom, Joy Kim, Hyeon U Park, Andrew Eldabh, Christopher Kalhorn, Kevin McGrail, Deepa Subramaniam, Walter C Jean, Sean P Collins

Open Access Short report

Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy?

Yassir Sbitti, Nabil Ismaili, Youssef Bensouda, Habiba Kadiri, Mohammed Ichou, Hassan Errihani

Open Access Case report

Pancytopenia associated with clonazepam

Marnelli A Bautista-Quach, Yu-Min Liao, Chung-Tsen Hsueh

Open Access Case report

Ring chromosome 18 abnormality in acute myelogenous leukemia: the clinical dilemma

Shanthi Sivendran, Stephen Gruenstein, Adriana K Malone, Vesna Najfeld

Open Access Review

Angiogenesis inhibitors in the treatment of prostate cancer

Clara Hwang, Elisabeth I Heath

Open Access Short report

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Matthias Schwenkglenks, Ruth Pettengell, Thomas D Szucs, Eva Culakova, Gary H Lyman

Open Access Research

Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells

Clement Yedjou, Paul Tchounwou, John Jenkins, Robert McMurray

Open Access Letter to the Editor

Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China

Rong Rong Liu, Ming Yue Wang, Yong Rong Lai

Open Access Case report

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma

Li Wang, Wen-Yu Shi, Zhi-Yuan Wu, Mariana Varna, Ai-Hua Wang, Li Zhou, Li Chen, Zhi-Xiang Shen, He Lu, Wei-Li Zhao, Anne Janin

Open Access Case report

Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report

Jun Wang, George W Saukel, Carlos A Garberoglio, Wichit Srikureja, Chung-Tsen Hsueh

Open Access Case report

Prozone effect of serum IgE levels in a case of plasma cell leukemia

Giampaolo Talamo, William Castellani, Nathan G Dolloff

Open Access Review

Role of Wnt canonical pathway in hematological malignancies

Xueling GE, Xin Wang

Open Access Letter to the Editor

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma

Jean-Christophe Ianotto, Adrian Tempescul, Jean-Richard Eveillard, Norbert André, Frederic Morel, Isabelle Quintin-Roué, Christian Berthou

Open Access Research

Autoimmune conditions and hairy cell leukemia: an exploratory case-control study

Lesley A Anderson, Eric A Engels

Open Access Research

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

Joseph Pidala, Jongphil Kim, Claudio Anasetti, Mohamed A Kharfan-Dabaja, Taiga Nishihori, Teresa Field, Janelle Perkins, Lia Perez, Hugo F Fernandez

Open Access Review

The clinical potential of microRNAs

Anuradha Budhu, Junfang Ji, Xin W Wang

Open Access Review

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

Antonio Sacco, Ghayas C Issa, Yong Zhang, Yang Liu, Patricia Maiso, Irene M Ghobrial, Aldo M Roccaro

Open Access Short report

CyberKnife for hilar lung tumors: report of clinical response and toxicity

Keith Unger, Andrew Ju, Eric Oermann, Simeng Suy, Xia Yu, Saloomeh Vahdat, Deepa Subramaniam, K William Harter, Sean P Collins, Anatoly Dritschilo, Eric Anderson, Brian T Collins

Open Access Research

The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1

Saad Z Usmani, Robert D Bona, Gabriela Chiosis, Zihai Li

Open Access Research

The frequency of NPM1 mutations in childhood acute myeloid leukemia

Maria Braoudaki, Chrissa Papathanassiou, Katerina Katsibardi, Natalia Tourkadoni, Kalliopi Karamolegou, Fotini Tzortzatou-Stathopoulou

Open Access Review

Treatment options for patients with triple-negative breast cancer

Rafael Santana-Davila, Edith A Perez

Open Access Research

Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells

Qiong Wu, Shu-Kui Qin, Feng-Meng Teng, Chang-Jie Chen, Rui Wang

Open Access Research

Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia

Xin Huang, Shaohua Chen, Qi Shen, Lijian Yang, Bo Li, Liye Zhong, Suxia Geng, Xin Du, Yangqiu Li

Open Access Review

Targeted therapy in lymphoma

Patrick B Johnston, RuiRong Yuan, Franco Cavalli, Thomas E Witzig

Open Access Research

Dysregulation of miR-15a and miR-214 in human pancreatic cancer

Xing J Zhang, Hua Ye, Cheng W Zeng, Bo He, Hua Zhang, Yue Q Chen

Open Access Review

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib

Guoqing Wei, Shamudheen Rafiyath, Delong Liu

Open Access Letter to the Editor

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia

Séverine Loisel, Karine Le Ster, Michèle Meyer, Christian Berthou, Pierre Youinou, Jean-Pierre Kolb, Christian Billard

Open Access Research

Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells

Ratana Banjerdpongchai, Prachya Kongtawelert, Orawan Khantamat, Chantragan Srisomsap, Daranee Chokchaichamnankit, Pantipa Subhasitanont, Jisnuson Svasti

Open Access Letter to the Editor

HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia

Sun Zi-Min, Liu Hui-Lan, Geng Liang-Quan, Wang Xin-Bing, Yao Wen, Liu Xin, Ding Kai-Yang, Han Yong-Sheng, Yang Hui-Zhi, Tang Bo-lin, Tong Juan, Zhu Wei-Bo, Wang Zu-Yi

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.